GlassScriptPhysician profile
Stanley G Kinkaid
NPI 1245282441
$936.26
in general payments reported to CMS, 2019-2025
17 companies · $35.33 in 2025
The $35.33 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $31.19 · 2022: $162 · 2023: $209 · 2024: $185 · 2025: $35.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $186.59 | 2019-2024 | Belbuca, Xtampza |
| Sentynl Therapeutics, INC. | $134.50 | 2019 | |
| Abbvie INC. | $98.53 | 2022-2024 | |
| Amgen INC. | $93.07 | 2020-2022 | |
| Novo Nordisk INC | $88.79 | 2023-2025 | Wegovy |
| Abbott Laboratories | $64.52 | 2019 | |
| Pfizer INC. | $51.95 | 2019 | |
| Scilex Pharmaceuticals INC. | $32.45 | 2022-2023 | Ztlido |
| Boston Scientific Corporation | $32.25 | 2019-2024 | |
| Ironwood Pharmaceuticals, INC | $24.99 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.87 | 2022 | |
| Painteq LLC | $21.85 | 2024 | Painteq |
| Novartis Pharmaceuticals Corporation | $18.94 | 2019 | |
| Forte Bio-Pharma LLC | $17.85 | 2023 | Prolate, Nalocet |
| Glaxosmithkline, LLC. | $17.47 | 2023 | Shingrix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $14.86 | 2024 | Dyanavel Xr |
| Bayer Healthcare Pharmaceuticals INC. | $13.78 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Kinkaid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.